UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 116

Sortiert nach

The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration

International journal of hematology, 2021-01, Vol.113 (1), p.100-105

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy

Scientific reports, 2021-03, Vol.11 (1), p.6362-6362, Article 6362

2021

Link zum Volltext

Verfügbarkeit prüfen

High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma

International journal of hematology, 2022-11, Vol.116 (5), p.712-722

2022

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

Blood, 2009-01, Vol.113 (2), p.396-402

2009

Link zum Volltext

Verfügbarkeit prüfen

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia

Journal of human genetics, 2010-11, Vol.55 (11), p.731-737

2010

Link zum Volltext

Verfügbarkeit prüfen

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

Blood, 2009-10, Vol.114 (15), p.3265-3275

2009

Link zum Volltext

Verfügbarkeit prüfen

Relationship between achievement of major molecular response or deep molecular response and nilotinib plasma concentration in patients with chronic myeloid leukemia receiving first-line nilotinib therapy

Cancer chemotherapy and pharmacology, 2022-05, Vol.89 (5), p.609-616

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone

Internal Medicine, 2019/12/01, Vol.58(23), pp.3461-3468

2019

Link zum Volltext

Verfügbarkeit prüfen

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging

Internal Medicine, 2017/05/15, Vol.56(10), pp.1247-1252

2017

Link zum Volltext

Verfügbarkeit prüfen

Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma

Annals of hematology, 2022-05, Vol.101 (5), p.979-989

2022

Link zum Volltext

Verfügbarkeit prüfen

Thrombocytopenia Caused by a Tea Beverage of Taxus yunnanensis (Chinese Yew)

Internal Medicine, 2019/11/01, Vol.58(21), pp.3153-3156

2019

Link zum Volltext

Verfügbarkeit prüfen

Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor

Cancer medicine (Malden, MA), 2023-02, Vol.12 (4), p.4250-4258

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma

International journal of hematology, 2018-11, Vol.108 (5), p.510-515

2018

Link zum Volltext

Verfügbarkeit prüfen

Relationship between clinical course of nivolumab-related myositis and immune status in a patient with Hodgkin’s lymphoma after allogeneic hematopoietic stem cell transplantation

International journal of hematology, 2019-03, Vol.109 (3), p.356-360

2019

Link zum Volltext

Verfügbarkeit prüfen

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)

Japanese journal of clinical oncology, 2021-07, Vol.51 (7), p.1059-1066

2021

Link zum Volltext

Verfügbarkeit prüfen

Influence of UGT1A1 6, 27, and 28 Polymorphisms on Nilotinib-induced Hyperbilirubinemia in Japanese Patients with Chronic Myeloid Leukemia

Drug metabolism and pharmacokinetics, 2014, Vol.29 (6), p.449-454

2014

Link zum Volltext

Verfügbarkeit prüfen

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma

International journal of hematology, 2012-11, Vol.96 (5), p.624-630

2012

Link zum Volltext

Verfügbarkeit prüfen

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

Experimental hematology & oncology, 2018-04, Vol.7 (1), p.9-9, Article 9

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation

Cancer chemotherapy and pharmacology, 2016-07, Vol.78 (1), p.111-118

2016

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum

International journal of hematology, 2017-05, Vol.105 (5), p.606-613

2017

Link zum Volltext

Verfügbarkeit prüfen

Characterization of target genes at the 2p15–16 amplicon in diffuse large B‐cell lymphoma

Cancer science, 2006-06, Vol.97 (6), p.499-504

2006

Link zum Volltext

Verfügbarkeit prüfen

Drug interaction between lenalidomide and itraconazole

American journal of hematology, 2012-03, Vol.87 (3), p.338-339

2012

Link zum Volltext

Verfügbarkeit prüfen

Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants

European journal of clinical pharmacology, 2013-06, Vol.69 (6), p.1321-1329

2013

Link zum Volltext

Verfügbarkeit prüfen

T-cell prolymphocytic leukemia in Japan: is it a variant?

International journal of hematology, 2012-06, Vol.95 (6), p.660-667

2012

Link zum Volltext

Verfügbarkeit prüfen

Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells

International journal of hematology, 2011-09, Vol.94 (3), p.230-240

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(113)
Berichte
(3)

Sprache

Englisch
(105)
Japanisch
(36)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(70)
Humans
(58)
Female
(36)
Oncology
(34)
Middle Aged
(33)
Male
(32)
Hematology
(29)
Adult
(28)
Medicine
(26)
Medicine & Public Health
(24)
Aged
(22)
Biological And Medical Sciences
(16)
Original Article
(16)
Medical Sciences
(15)
Lymphoma
(14)
Aged, 80 And Over
(13)
Hematologic And Hematopoietic Diseases
(12)
Treatment Outcome
(12)
Chronic Myeloid Leukemia
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The BCRP inhibitor febuxostat enhances the effect of nilotinib by regulation of intracellular concentration

Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy

High baseline total lesion glycolysis predicts early progression of disease within 24 months in patients with high-tumor-burden follicular lymphoma

MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes

Influence of CYP3A5 and drug transporter polymorphisms on imatinib trough concentration and clinical response among patients with chronic phase chronic myeloid leukemia

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer–cell lymphoma/leukemia

Relationship between achievement of major molecular response or deep molecular response and nilotinib plasma concentration in patients with chronic myeloid leukemia receiving first-line nilotinib therapy

Multiparameter Flow Cytometry for the Identification of Neoplastic Plasma Cells in POEMS Syndrome with IgG-kappa Gammopathy: Successful Treatment Using Lenalidomide and Dexamethasone

Two Cases of Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with High Serum Procalcitonin Levels, Including the First Case Complicated with Adrenal Hemorrhaging

Bendamustine plus rituximab in Japanese patients with relapsed or refractory diffuse large B-cell lymphoma

Thrombocytopenia Caused by a Tea Beverage of Taxus yunnanensis (Chinese Yew)

Deep molecular response in patients with chronic phase chronic myeloid leukemia treated with the plasminogen activator inhibitor‐1 inhibitor TM5614 combined with a tyrosine kinase inhibitor

Safety and efficacy of high-dose ranimustine (MCNU) containing regimen followed by autologous stem cell transplantation for diffuse large B-cell lymphoma

Relationship between clinical course of nivolumab-related myositis and immune status in a patient with Hodgkin’s lymphoma after allogeneic hematopoietic stem cell transplantation

Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)

Influence of UGT1A1 6, 27, and 28 Polymorphisms on Nilotinib-induced Hyperbilirubinemia in Japanese Patients with Chronic Myeloid Leukemia

Safety and feasibility of high-dose ranimustine (MCNU), carboplatin, etoposide, and cyclophosphamide (MCVC) therapy followed by autologous stem cell transplantation for malignant lymphoma

Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia

Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation

Evaluation of the safety and efficacy of recombinant soluble thrombomodulin for patients with disseminated intravascular coagulation associated with acute leukemia: multicenter prospective study by the Tohoku Hematology Forum

Characterization of target genes at the 2p15–16 amplicon in diffuse large B‐cell lymphoma

Drug interaction between lenalidomide and itraconazole

Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants

T-cell prolymphocytic leukemia in Japan: is it a variant?

Age-associated alteration of γδ T-cell repertoire and different profiles of activation-induced death of Vδ1 and Vδ2 T cells

Suchergebnisse filtern